164: PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). (January 2017)

Record Type:
Journal Article
Title:
164: PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). (January 2017)
Main Title:
164: PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)
Authors:
Kordbacheh, T.
Chan, C.
Bossons, A.
Franks, K.
McDonald, F.
Forster, M.
Mendes, R.
Quezada, S.
Dovedi, S.
Ralph, C.
Popat, S.
Harrington, K.
Melcher, A.
Popple, A.
Illidge, T.
Faivre-Finn, C.
Abstract:
Is Part Of:
Lung cancer. Volume 103(2017)Supplement 1
Journal:
Lung cancer
Issue:
Volume 103(2017)Supplement 1
Issue Display:
Volume 103, Issue 2017 (2017)
Year:
2017
Volume:
103
Issue:
2017
Issue Sort Value:
2017-0103-2017-0000
Page Start:
S75
Page End:
S76
Publication Date:
2017-01
Subjects:
Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:
http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0169-5002(17)30214-3 ↗
Languages:
English
ISSNs:
0169-5002
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
1561.xml